Strides Pharma Intl Drug Patent Portfolio
Strides Pharma Intl owns 1 orange book drug protected by 2 US patents Given below is the list of Strides Pharma Intl's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5612367 | Method of enhancing bioavailability of pharmaceutical agents | 18 Mar, 2014 | Expired |
| US5482963 | Pharmaceutical agents useful as leukotriene antagonists | 09 Jan, 2013 | Expired |
Strides Pharma Intl's Family Patents
Recently granted tentative Approvals to Strides Pharma Intl
These tentative approvals reflect continued regulatory progress across both innovative and generic submissions related to Strides Pharma Intl's portfolio.
Innovator tentative approvals
| Drug Name | Active Ingredient | Submission Type | Submission Category | Submission Date |
|---|---|---|---|---|
| Stavudine; Lamivudine; Efavirenz | Stavudine; Lamivudine; Efavirenz |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 4 - New Combination | 01 Jun, 2007 |
| Stavudine; Lamivudine | Stavudine; Lamivudine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 4 - New Combination | 13 Mar, 2007 |
| Lamivudine/zidovudine 150 Mg/300 Mg Tablets Co-packaged With Nevirapine 200 Mg Tablets | Lamivudine; Zidovudine; Nevirapine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 4 - New Combination | 02 Mar, 2007 |
Generic tentative approvals
| Drug Name | Active Ingredient | Submission Type | Submission Category | Submission Date |
|---|---|---|---|---|
| Lamivudine | Lamivudine |
SUPPL-8
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Labeling | 14 Dec, 2016 |
| Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate |
SUPPL-6
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Labeling | 07 Dec, 2016 |
| Stavudine | Stavudine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 28 Aug, 2006 |
Explore deeper patents analysis
Strides Pharma Intl Drug List
Given below is the complete list of Strides Pharma Intl's drugs and the patents protecting them.
1. Accolate
Accolate is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5612367 | Method of enhancing bioavailability of pharmaceutical agents |
18 Mar, 2014
(11 years ago)
| Expired |
| US5482963 | Pharmaceutical agents useful as leukotriene antagonists |
09 Jan, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Accolate's drug page